Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Multiple Sclerosis Journal - Experimental, Translational and Clinical is Scopus-indexed (Q2, CiteScore 3.9), WoS ESCI, DOAJ. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 2055-2173Verify ISSN ↗
Publisher: SAGE Publications Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 189 / 403 | 53rd | Q2 |
| Cellular and Molecular Neuroscience | 71 / 102 | 30th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q2, CiteScore 3.9.
Multiple Sclerosis Journal - Experimental, Translational and Clinical is Q2 in Neurology (clinical) (rank 189 of 403) and Q3 in Cellular and Molecular Neuroscience (rank 71 of 102), by CiteScore 2025.
Multiple Sclerosis Journal - Experimental, Translational and Clinical is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.9, which places it in quartile Q2 at the 53rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.665, quartile Q2, with an H-index of 37.
The publisher lists an article processing charge of about US$2,650 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Multiple Sclerosis Journal - Experimental, Translational and Clinical is published by SAGE Publications Inc. Its ISSN is 2055-2173.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Multiple Sclerosis Journal - Experimental, Translational and Clinical has an h-index of 41 and a 2-year mean of 1.13 citations per paper (OpenAlex). Its Scopus CiteScore is 3.9, quartile Q2. On 2-year citations it ranks #249 of 403 Scopus journals in Neurology (clinical).
Multiple Sclerosis Journal - Experimental, Translational and Clinical published 63 papers in 2025; its busiest recent year was 2020 with 68. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from United States (42.7%), Germany (6.8%) and Canada (6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.